Cellebrite director granted 15,190 RSUs
Cellebrite director Dafna Gruber received a new RSU grant that increases her direct equity holdings in CLBT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cellebrite DI Ltd. (symbol: CLBT) is the issuer of record for a Form 4 filing submitted to the SEC. Gruber Dafna reported acquisition or exercise transactions in this Form 4 filing.
Cellebrite DI Ltd. (CLBT) reported that director Dafna Gruber received an equity award of 15,190 restricted share units (RSUs) on September 17, 2026. The RSUs will vest on September 17, 2027, each settling into one ordinary share, bringing her directly held position to 43,109 ordinary shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary shares, par value NIS 0.00001 F1 | 15,190 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.
Key Figures
Key Terms
RSUs financial
contingent right financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Cellebrite (CLBT) disclose for director Dafna Gruber?
When do the newly granted RSUs to the Cellebrite (CLBT) director vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.